CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Common Stock	Retained Earnings	Foreign Currency Translation Adjustments	Accumulated income (loss) on derivatives	Pension adjustments	Total
Balance at the beginning at Dec. 31, 2023	$ 95,937	$ 165,813	$ (13,256)	$ 3,425	$ (344)	$ 251,575
Balance at the beginning (in shares) at Dec. 31, 2023	16,308
Increase (Decrease) in Stockholders' Equity
Stock transactions under employee benefit stock plans	$ 1,564					1,564
Stock transactions under employee benefit stock plans (in shares)	58
Issuance of restricted stock, net of forfeitures	$ (139)					(139)
Issuance of restricted stock, net of forfeitures (in shares)	167
Share issuance in connection with acquisitions	$ 6,250					6,250
Share issuance in connection with acquisitions (in shares)	203
Share issuance to settle contingent consideration	$ 4,874					4,874
Share issuance to settle contingent consideration (in shares)	174
Stock-based compensation expense	$ 1,211					1,211
Shares withheld for payment of employee payroll taxes	$ (121)					(121)
Shares withheld for payment of employee payroll taxes (in shares)	(4)
Comprehensive income (loss)			(4,408)	(102)		(4,510)
Tax effect of derivative transactions				24		24
Net income		6,902				6,902
Dividends to stockholders		(500)				(500)
Balance at the ending at Mar. 31, 2024	$ 109,576	172,215	(17,664)	3,347	(344)	267,130
Balance at the ending (in shares) at Mar. 31, 2024	16,906
Balance at the beginning at Dec. 31, 2023	$ 95,937	165,813	(13,256)	3,425	(344)	251,575
Balance at the beginning (in shares) at Dec. 31, 2023	16,308
Increase (Decrease) in Stockholders' Equity
Net income						8,052
Balance at the ending at Jun. 30, 2024	$ 109,203	172,862	(18,842)	2,836	(344)	265,715
Balance at the ending (in shares) at Jun. 30, 2024	16,841
Balance at the beginning at Mar. 31, 2024	$ 109,576	172,215	(17,664)	3,347	(344)	267,130
Balance at the beginning (in shares) at Mar. 31, 2024	16,906
Increase (Decrease) in Stockholders' Equity
Issuance of restricted stock, net of forfeitures (in shares)	(23)
Stock-based compensation expense	$ 1,073					1,073
Shares withheld for payment of employee payroll taxes	$ (1,446)					(1,446)
Shares withheld for payment of employee payroll taxes (in shares)	(42)
Comprehensive income (loss)			(1,178)	(673)		(1,851)
Tax effect of derivative transactions				162		162
Net income		1,150				1,150
Dividends to stockholders		(503)				(503)
Balance at the ending at Jun. 30, 2024	$ 109,203	172,862	(18,842)	2,836	(344)	265,715
Balance at the ending (in shares) at Jun. 30, 2024	16,841
Balance at the beginning at Dec. 31, 2024	$ 111,024	177,013	(25,289)	1,975	131	$ 264,854
Balance at the beginning (in shares) at Dec. 31, 2024	16,810					16,810
Increase (Decrease) in Stockholders' Equity
Stock transactions under employee benefit stock plans	$ 886					$ 886
Stock transactions under employee benefit stock plans (in shares)	33
Issuance of restricted stock, net of forfeitures	$ (11)					(11)
Issuance of restricted stock, net of forfeitures (in shares)	135
Stock-based compensation expense	$ 920					920
Shares withheld for payment of employee payroll taxes	$ (97)					(97)
Shares withheld for payment of employee payroll taxes (in shares)	(3)
Comprehensive income (loss)			3,862	(856)		3,006
Tax effect of derivative transactions				231		231
Net income		3,557				3,557
Dividends to stockholders		(518)				(518)
Balance at the ending at Mar. 31, 2025	$ 112,722	180,052	(21,427)	1,350	131	272,828
Balance at the ending (in shares) at Mar. 31, 2025	16,975
Balance at the beginning at Dec. 31, 2024	$ 111,024	177,013	(25,289)	1,975	131	$ 264,854
Balance at the beginning (in shares) at Dec. 31, 2024	16,810					16,810
Increase (Decrease) in Stockholders' Equity
Net income						$ 9,174
Balance at the ending at Jun. 30, 2025	$ 112,587	185,187	(9,783)	940	131	$ 289,062
Balance at the ending (in shares) at Jun. 30, 2025	16,938					16,938
Balance at the beginning at Mar. 31, 2025	$ 112,722	180,052	(21,427)	1,350	131	$ 272,828
Balance at the beginning (in shares) at Mar. 31, 2025	16,975
Increase (Decrease) in Stockholders' Equity
Issuance of restricted stock, net of forfeitures	$ (43)					(43)
Issuance of restricted stock, net of forfeitures (in shares)	6
Stock-based compensation expense	$ 835					835
Shares withheld for payment of employee payroll taxes	$ (927)					(927)
Shares withheld for payment of employee payroll taxes (in shares)	(43)
Comprehensive income (loss)			11,644	(540)		11,104
Tax effect of derivative transactions				130		130
Net income		5,617				5,617
Dividends to stockholders		(482)				(482)
Balance at the ending at Jun. 30, 2025	$ 112,587	$ 185,187	$ (9,783)	$ 940	$ 131	$ 289,062
Balance at the ending (in shares) at Jun. 30, 2025	16,938					16,938

ALLIENT INC 10-Q